
Physician, MBA, CEO, Visiting Professor for Pharma Medicine, accredited Journalist, Business Angel.
1st professional life: 12 years shaping and leading international clinical drug development in Pharma.
2nd professional life: In 1994, I founded the centralized laboratory INTERLAB to deliver laboratory support and logistics services to Pharma companies performing multicentre and multinational clinical studies. In 2014, INTERLAB was sold to SYNLAB, a leading European lab corporation. During the following four years, through further acquisitions I successfully expanded this international lab services business on behalf of SYNLAB as their Executive Vice President.
3rd professional life: Since 2018, boutique advisor to and investor in future-oriented healthcare teams (refer to SchulzInternational @ PresseKontext), a creator of tailored press communication stories for a variety of industries (refer to PresseKontext). Expert for knowledge consulting companies.
Dr. Schulz was working for 22 years in industry and 8 years in advisory.
Education in brief: Medicine, Business Administration, Journalist, Good Clinical Practices
Membership in prof. associations: various scientific associations
Countries of Work Experience: Europe, North America, South Africa, China, India, Australia, South & Central America
Dr. Schulz joined CBA in July 2022 as Consulting Professional.
This website uses cookies to enhance your experience. Some are essential for site functionality, while others help us analyze and improve your usage experience. Please review your options and make your choice.
If you are under 16 years old, please ensure that you have received consent from your parent or guardian for any non-essential cookies.
Your privacy is important to us. You can adjust your cookie settings at any time. For more information about how we use data, please read our privacy policy. You may change your preferences at any time by clicking on the settings button below.
Note that if you choose to disable some types of cookies, it may impact your experience of the site and the services we are able to offer.
Some required resources have been blocked, which can affect third-party services and may cause the site to not function properly.
This website uses cookies to enhance your browsing experience and ensure the site functions properly. By continuing to use this site, you acknowledge and accept our use of cookies.
![cba logo1[1]](https://cba.associates/wp-content/uploads/2026/02/cba-logo11.jpg)

![companies wanted1[1]](https://cba.associates/wp-content/uploads/2026/02/companies-wanted11.png)
![FastMatch logo with Buyer Finder transparent new 11[1]](https://cba.associates/wp-content/uploads/2026/02/FastMatch-logo-with-Buyer-Finder-transparent-new_111.png)